Association of personalised care plans with monitoring and control of clinical outcomes, prescription of medication and utilisation of primary care services in patients with type 2 diabetes: an observational real-world study

• Main Authors: Mikkola, Ilona, Morgan, Simon, Winell, Klas, Jokelainen, Jari, Frittitta, Lucia, Heikkala, Eveliina, Hagnäs, Maria
• Format: Text
• Language: unknown
• Published: Taylor & Francis 2022
• Subjects: Medicine; Biotechnology; 69999 Biological Sciences not elsewhere classified; FOS Biological sciences; Cancer; Science Policy; 111714 Mental Health; FOS Health sciences; 110309 Infectious Diseases; 60506 Virology; Rovaniemi
• Online Access: https://dx.doi.org/10.6084/m9.figshare.19164690; https://tandf.figshare.com/articles/journal_contribution/Association_of_personalised_care_plans_with_monitoring_and_control_of_clinical_outcomes_prescription_of_medication_and_utilisation_of_primary_care_services_in_patients_with_type_2_diabetes_an_observational_real-world_study/19164690

To study the association of personalised care plans with monitoring and controlling clinical outcomes, prescription of cardiovascular and antihyperglycaemic medication and utilisation of primary care services in patients with type 2 diabetes (T2D). Primary care T2D outpatients from the Rovaniemi Health Centre. The municipal health centre, Rovaniemi, Finland. A cross-sectional, observational, retrospective register-based study. The patients were divided into three groups: ‘no care plan entries’ (usual care); ‘1–2 care plan entries’; and ‘3 or more care plan entries’. Monitoring of clinical and biochemical measures, achievement of treatment targets, prescription of cardiovascular and antihyperglycemic medication, and use of primary care services. A total of 5104 patients with T2D (mean age 65.5 years (SD 12.4)), of which 67% had at least one care plan entry. Compared to usual care, the establishment of a care plan (either care plan group) was associated with better monitoring of glycosylated haemoglobin A1c, low-density-lipoprotein cholesterol, systolic blood pressure (sBP), and renal function, and there was more frequent prescription of all cardiovascular and antihyperglycemic medication. Patients in either care plan group were more likely to achieve sBP target ( p p Establishment of a care plan is associated with more intensive and focussed care of patients with T2D. The appropriate use of primary care resources is essential and personalised care plans may contribute to the treatment of patients with T2D.Key PointsCare planning aims to empower patients with type 2 diabetes. This study demonstrates that personalised care planning is associated withmore frequent monitoring for clinical outcomes,more frequent prescription of cardiovascular and antihyperglycemic medication andmore frequent utilisation of planned diabetes consultations when compared to usual care. Care planning aims to empower patients with type 2 diabetes. This study demonstrates that personalised care planning is associated with more frequent monitoring for clinical outcomes, more frequent prescription of cardiovascular and antihyperglycemic medication and more frequent utilisation of planned diabetes consultations when compared to usual care.